Microbot Medical Inc.
HealthcareNASDAQ:MBOT · NASDAQ Capital Market
-$0.04 today
Vol 0.91M · Avg 1.68M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $3.7M |
| Short-term Investments | $68.8M |
| Receivables | $105.0K |
| Inventory | $2.3M |
| Other Current | $1.7M |
| Total Current Assets | $76.5M |
| PP&E (Net) | $1.1M |
| Other Non-current | $480.0K |
| Total Non-current Assets | $1.5M |
| Total Assets | $78.1M |
Analysis
Selected assets total $78.1M for Latest. The largest visible component is Short-term Investments at $68.8M, about 88.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.9M +25.6% | $3.1M +26.2% | $2.5M -2.0% | $2.5M -81.3% | $13.5M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $74.7M +3069.8% | $2.4M -39.9% | $3.9M -32.0% | $5.8M +188.1% | $2.0M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $241.0K -19.7% | $300.0K -79.8% | $1.5M +1343.7% | $103.0K -40.8% | $174.0K | $533.8M | $399.4M | -$1.7B |
| Inventory | $584.0K | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $405.0K +726.5% | $49.0K +0.0% | $49.0K +1533.3% | $3.0K -96.6% | $87.0K | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $79.8M +1271.7% | $5.8M -26.5% | $7.9M -10.1% | $8.8M -44.5% | $15.9M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $926.0K +336.8% | $212.0K -47.8% | $406.0K -43.8% | $723.0K -18.6% | $888.0K | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $796.0K | $0 | $0 | $0 | $0 | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $1.7M +712.3% | $212.0K -47.8% | $406.0K -43.8% | $723.0K -18.6% | $888.0K | -$15.3B | $14.8B | $11.3B |
| Total Assets | $81.5M +1252.1% | $6.0M -27.6% | $8.3M -12.7% | $9.5M -43.1% | $16.8M | $13.3B | $11.9B | $10.6B |
| Account Payables | $511.0K +209.7% | $165.0K -53.8% | $357.0K +207.8% | $116.0K -58.4% | $279.0K | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $296.0K | $0 | $0 -100.0% | $283.0K | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $2.6M +84.9% | $1.4M +75.9% | $804.0K +169.8% | $298.0K | $0 | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $3.4M +39.1% | $2.5M -35.0% | $3.8M +83.0% | $2.1M +4.3% | $2.0M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $0 | $0 | $0 | $0 | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $0 | $0 | $0 | $0 | $0 | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $569.0K +1287.8% | $41.0K +2.5% | $40.0K -77.7% | $179.0K -55.5% | $402.0K | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $4.0M +59.5% | $2.5M -34.6% | $3.8M +70.2% | $2.2M -5.8% | $2.4M | $14.7B | $3.7B | $9.6B |
| Common Stock | $672.0K +244.6% | $195.0K +65.3% | $118.0K +47.5% | $80.0K +11.1% | $72.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$104.1M -14.5% | -$90.9M -14.4% | -$79.5M -15.6% | -$68.8M -23.7% | -$55.6M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $77.6M +2097.0% | $3.5M -21.6% | $4.5M -38.2% | $7.3M -49.3% | $14.4M | $9.1B | $7.7B | $3.3B |
| Total Debt | $865.0K +679.3% | $111.0K -51.9% | $231.0K -50.0% | $462.0K -32.1% | $680.0K | $724.2M | $410.6M | $399.4M |
| Net Debt | -$3.0M -1.5% | -$3.0M -34.2% | -$2.2M -8.8% | -$2.1M +83.9% | -$12.8M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Ovid Therapeutics Inc.
NASDAQ:OVID
$303.33M
Oramed Pharmaceuticals Inc.
NASDAQ:ORMP
$158.38M
Context Therapeutics Inc.
NASDAQ:CNTX
$127.71M
Cardiol Therapeutics Inc.
NASDAQ:CRDL
$115.23M
AVITA Medical, Inc.
NASDAQ:RCEL
$97.14M
Vivani Medical, Inc.
NASDAQ:VANI
$64.99M
Clene Inc.
NASDAQ:CLNN
$60.20M
DocGo Inc.
NASDAQ:DCGO
$57.25M
Zentek Ltd.
ZTEK
$49.15M
InspireMD, Inc.
NSPR
$34.19M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does MBOT have?
Microbot Medical Inc. (MBOT) reported $3.91M in cash and equivalents in fiscal 2025.
How much debt does MBOT carry?
Microbot Medical Inc. (MBOT) reported $865,000.00 of total debt, with net debt of -$3,047,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.